TITLE

New drug and biological product approvals, 2007

AUTHOR(S)
Traynor, Kate
PUB. DATE
February 2008
SOURCE
American Journal of Health-System Pharmacy;2/1/2008, Vol. 65 Issue 3, p190
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article offers news briefs related to drug approvals in the U.S. for 2008. The marketing of maraviroc, a chemokine receptor 5 (CCR5) blocker, was approved by the Food and Drug Administration (FDA) in August 2007. The FDA gave approval for three products intended for the treatment of advanced forms of cancer. Sanofi's H5N1 vaccine and ACAM2000 were made to plug holes in the nation's biodefense and preparedness programs and are not available to the general public.
ACCESSION #
31142344

 

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics